Bukwang's Lebovir received grand prix in new drug development.

Lebovir, the 11th Korean new drug developed by Bukwang with 110 billion won of investment during the past 12 years from its preclinical, clinical, synthesis and dosage form
research and development received the grand prix in the occasion of the general congress of the Korean Drug Research Association and the 8th Korea New Drug Development Award ceremony at SNU Samsung convention center on Feb...